Processa Pharmaceuticals Inc
(PCSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | -4,526 | N/A |
| Depreciation Amortization | 428 | N/A |
| Accounts receivable | 18 | N/A |
| Accounts payable and accrued liabilities | 77 | N/A |
| Other Working Capital | -253 | N/A |
| Other Operating Activity | 1,564 | 0 |
| Operating Cash Flow | $-2,692 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -11 | N/A |
| Other Investing Activity | -34 | 0 |
| Investing Cash Flow | $-45 | $N/A |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 2,244 | N/A |
| Debt Repayment | -46 | N/A |
| Common Stock Issued | 366 | N/A |
| Other Financing Activity | 10 | 0 |
| Financing Cash Flow | $2,575 | $N/A |
| Beginning Cash Position | 187 | N/A |
| End Cash Position | 25 | N/A |
| Net Cash Flow | $-162 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -2,692 | N/A |
| Capital Expenditure | -11 | N/A |
| Free Cash Flow | -2,703 | 0 |